179 related articles for article (PubMed ID: 28177779)
1. The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies.
Sosenko JM; Yu L; Skyler JS; Krischer JP; Gottlieb PA; Boulware D; Miao D; Palmer JP; Steck AK
Diabetes Technol Ther; 2017 Mar; 19(3):183-187. PubMed ID: 28177779
[TBL] [Abstract][Full Text] [Related]
2. Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.
Miao D; Steck AK; Zhang L; Guyer KM; Jiang L; Armstrong T; Muller SM; Krischer J; Rewers M; Yu L;
Diabetes Technol Ther; 2015 Feb; 17(2):119-27. PubMed ID: 25562486
[TBL] [Abstract][Full Text] [Related]
3. ECL-IAA and ECL-GADA Can Identify High-Risk Single Autoantibody-Positive Relatives in the TrialNet Pathway to Prevention Study.
Steck AK; Fouts A; Miao D; Zhao Z; Dong F; Sosenko J; Gottlieb P; Rewers MJ; Yu L;
Diabetes Technol Ther; 2016 Jul; 18(7):410-4. PubMed ID: 26991969
[TBL] [Abstract][Full Text] [Related]
4. Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?
Fouts A; Pyle L; Yu L; Miao D; Michels A; Krischer J; Sosenko J; Gottlieb P; Steck AK;
Diabetes Care; 2016 Oct; 39(10):1738-44. PubMed ID: 27456836
[TBL] [Abstract][Full Text] [Related]
5. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
[TBL] [Abstract][Full Text] [Related]
6. GAD65 autoantibodies detected by electrochemiluminescence assay identify high risk for type 1 diabetes.
Miao D; Guyer KM; Dong F; Jiang L; Steck AK; Rewers M; Eisenbarth GS; Yu L
Diabetes; 2013 Dec; 62(12):4174-8. PubMed ID: 23974918
[TBL] [Abstract][Full Text] [Related]
7. Islet Autoantibody Measurements from Dried Blood Spots on Filter Paper Strongly Correlate to Serum Levels.
Simmons KM; Alkanani AK; McDaniel KA; Goyne C; Miao D; Zhao Z; Yu L; Michels AW
PLoS One; 2016; 11(11):e0166213. PubMed ID: 27846247
[TBL] [Abstract][Full Text] [Related]
8. Proinsulin/Insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity.
Yu L; Dong F; Miao D; Fouts AR; Wenzlau JM; Steck AK
Diabetes Care; 2013 Aug; 36(8):2266-70. PubMed ID: 23423694
[TBL] [Abstract][Full Text] [Related]
9. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes.
Krischer JP; Cuthbertson DD; Yu L; Orban T; Maclaren N; Jackson R; Winter WE; Schatz DA; Palmer JP; Eisenbarth GS
J Clin Endocrinol Metab; 2003 Jan; 88(1):103-8. PubMed ID: 12519837
[TBL] [Abstract][Full Text] [Related]
10. A multiplex assay combining insulin, GAD, IA-2 and transglutaminase autoantibodies to facilitate screening for pre-type 1 diabetes and celiac disease.
Zhao Z; Miao D; Michels A; Steck A; Dong F; Rewers M; Yu L
J Immunol Methods; 2016 Mar; 430():28-32. PubMed ID: 26809048
[TBL] [Abstract][Full Text] [Related]
11. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
Giannopoulou EZ; Winkler C; Chmiel R; Matzke C; Scholz M; Beyerlein A; Achenbach P; Bonifacio E; Ziegler AG
Diabetologia; 2015 Oct; 58(10):2317-23. PubMed ID: 26138334
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population.
Kukko M; Kimpimäki T; Korhonen S; Kupila A; Simell S; Veijola R; Simell T; Ilonen J; Simell O; Knip M
J Clin Endocrinol Metab; 2005 May; 90(5):2712-7. PubMed ID: 15872335
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) participants.
Sosenko JM; Skyler JS; Palmer JP; Krischer JP; Cuthbertson D; Yu L; Schatz DA; Orban T; Eisenbarth G;
Diabetes Care; 2011 Nov; 34(11):2435-7. PubMed ID: 21911777
[TBL] [Abstract][Full Text] [Related]
14. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
[TBL] [Abstract][Full Text] [Related]
16. Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay.
Yu L
Methods Mol Biol; 2016; 1433():85-91. PubMed ID: 26659802
[TBL] [Abstract][Full Text] [Related]
17. A simple screening method for individuals at risk of developing type 1 diabetes: measurement of islet cell autoantibodies (GADA, IA-2A, and IAA) on dried capillary blood spots collected on filter paper.
Siraj ES; Rogers DG; Gupta MK; Reddy SS
Horm Metab Res; 2012 Oct; 44(11):855-60. PubMed ID: 22893260
[TBL] [Abstract][Full Text] [Related]
18. Reactivity to N-Terminally Truncated GAD65(96-585) Identifies GAD Autoantibodies That Are More Closely Associated With Diabetes Progression in Relatives of Patients With Type 1 Diabetes.
Williams AJ; Lampasona V; Wyatt R; Brigatti C; Gillespie KM; Bingley PJ; Achenbach P
Diabetes; 2015 Sep; 64(9):3247-52. PubMed ID: 26001397
[TBL] [Abstract][Full Text] [Related]
19. The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients.
Sosenko JM; Skyler JS; Palmer JP; Krischer JP; Yu L; Mahon J; Beam CA; Boulware DC; Rafkin L; Schatz D; Eisenbarth G; ;
Diabetes Care; 2013 Sep; 36(9):2615-20. PubMed ID: 23818528
[TBL] [Abstract][Full Text] [Related]
20. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
Weber P; Ambrosova P; Canov P; Weberova D; Kuklinek P; Meluzinova H; Matejovska-Kubesova H; Cejkova P; Bielakova K; Cerna M
Adv Gerontol; 2011; 24(2):312-8. PubMed ID: 21957594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
